|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| NET REVENUE | |||||
| COST OF REVENUE | |||||
| GROSS PROFIT | |||||
| SELLING, GENERAL AND ADMINISTRATIVE, RESEARCH AND DEVELOPMENT EXPENSES | |||||
| SELLING, GENERAL AND ADMINISTRATIVE | |||||
| RESEARCH AND DEVELOPMENT EXPENSES | |||||
| LOSS FROM OPERATIONS | |||||
| Interest income (expense), net | |||||
| Investment loss | |||||
| Loss on disposal of long term investment | |||||
| Share of results of associates | |||||
| Grant income | |||||
| Other Income (expenses) | |||||
| Total other expense | |||||
| LOSS BEFORE INCOME TAX PROVISION | |||||
| INCOME TAX EXPENSE/(BENEFIT) | |||||
| NET LOSS | |||||
| Less: net loss attributable to non-controlling interest | |||||
| NET LOSS ATTRIBUTABLE TO BGM Group Ltd. | |||||
| OTHER COMPREHENSIVE LOSS | |||||
| Foreign currency translation adjustment | |||||
| COMPREHENSIVE LOSS | |||||
| Less: comprehensive loss attributable to non - controlling interests | |||||
| COMPREHENSIVE LOSS ATTRIBUTABLE TO BGM Group Ltd. | |||||
| Earnings (loss) per common share - basic (in dollar per share) | |||||
| Earnings (loss) per common share - diluted (in dollar per share) | |||||
| Weighted average shares - basic (in shares) | |||||
| Weighted average shares - diluted (in shares) | |||||
Loading...